Inhibition of myosin ATPase activity by human myasthenia gravis antibodies reactive with the acetylcholine receptor

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Antibodies, obtained from myasthenia gravis patients, with reactivity for an immunodominant region of the nieotinic acetylcholine receptor were found to also react with muscle myosin. Since amino acid sequence analyses have previously suggested possible serological relationships between AChR and a head region sequence of myosin heavy chain, cross-reactive antibodies were examined for their ability to interfere with ATPase activities associated with this region of myosin. Results indicated that AChR-specific antibodies purified from MG patient serum by binding to and elution from antigen columns were found to inhibit Ca2+-dependent, myosin-associated ATPase activity; interestingly, this inhibition appeared to be relatively selective in that neither K+(EDTA)-dependent nor Mg2+-dependent ATPase activities were sensitive to antibody-mediated interference.

Original languageEnglish (US)
Pages (from-to)50-52
Number of pages3
JournalFEBS Letters
Volume318
Issue number1
DOIs
StatePublished - Feb 22 1993

Keywords

  • ATPase inhibition
  • Acetylcholine receptor antibody
  • Acetylcholine receptor/myosin cross-reactivity
  • Main immunogenic region
  • Myosin ATPase

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Fingerprint Dive into the research topics of 'Inhibition of myosin ATPase activity by human myasthenia gravis antibodies reactive with the acetylcholine receptor'. Together they form a unique fingerprint.

  • Cite this